Pharmaceutical company Allergan has acquired all assets of biotechnology company RetroSense Therapeutics through an all-cash transaction worth $60m.
According to the agreement, Allergan will be responsible to pay potential regulatory and milestone-based payments to RetroSense.
Go deeper with GlobalData
The acquisition enables Allergan to further advance its ongoing development programmes for critical diseases.
Asahi Glass plans to expand its business through its recent acquisition of contract manufacturing company Biomeva.
The target company is a subsidiary of Biomeva Holding that manufactures and distributes biologics, active pharmaceutical ingredients (APIs) and therapeutic proteins, while the acquirer is a glass company based in Japan.
See Also:
Image: Allergan has acquired RetroSense Therapeutics. Photo: courtesy of Coolcaesar at the English language Wikipedia.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
